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ABSTRACT Custom genome editing has become an essential element of molecular biology. In particular,
the generation of fusion constructs with epitope tags or fluorescent proteins at the genomic locus facilitates
the analysis of protein expression, localization, and interaction partners at physiologic levels. Following up
on our initial publication, we now describe a considerably simplified, more efficient, and readily scalable
experimental workflow for PCR-based genome editing in cultured Drosophila melanogaster cells. Our
analysis at the act5C locus suggests that PCR-based homology arms of 60 bp are sufficient to reach
targeting efficiencies of up to 80% after selection; extension to 80 bp (PCR) or 500 bp (targeting vector)
did not further improve the yield. We have expanded our targeting system to N-terminal epitope tags; this
also allows the generation of cell populations with heterologous expression control of the tagged locus via
the copper-inducible mtnDE promoter. We present detailed, quantitative data on editing efficiencies for
several genomic loci that may serve as positive controls or benchmarks in other laboratories. While our first
PCR-based editing approach offered only blasticidin-resistance for selection, we now introduce puromycin-
resistance as a second, independent selection marker; it is thus possible to edit two loci (e.g., for coimmu-
noprecipitation) without marker removal. Finally, we describe a modified FLP recombinase expression
plasmid that improves the efficiency of marker cassette FLP-out. In summary, our technique and reagents










Genome editing with the help of the CRISPR/cas system has become an
indispensable part of our toolbox for molecular biology. The CRISPR
“revolution” has shifted our attention from cloning work in the context
of plasmids or bacterial artificial chromosomes to the modification
of genes in their chromosomal context. The creation of a defined
DNA double-strand break can either be followed by erroneous
repair (end-joining activities), leading to targeted mutagenesis,
or by homology-directed repair. The latter offers the possibility
to introduce an experimentally provided, custom-modified homolo-
gous recombination (HR) donor into a desired locus (Doudna and
Charpentier 2014). Various methods that combine programmable
cleavage of DNA by CRISPR/cas9 with introduced HR donors in cell
culture have been described (e.g., Bassett et al. 2014; Bottcher et al.
2014; Byrne et al. 2014; Fetter et al. 2015; Fu et al. 2014a; Li et al.
2014; Wyvekens et al. 2015). These strategies can be broadly grouped
according to the particular type of HR donor material employed:
Cloned homology arms, single-stranded synthetic oligonucleo-
tides, or PCR-products with flanking homology regions. We have
previously presented a protocol for cultured Drosophila mela-
nogaster cells that employs PCR to generate both an expression
cassette for the cas9-programming sgRNA and HR donors for
selectable genome modification. In this publication, we describe
several technical improvements to our original protocol, two exper-
imental extensions (N-terminal epitope tags and an independent
selection marker), and an improved FLP recombinase expression
vector. In addition, we provided detailed protocols for use in the
laboratory as Supplemental Material, File S1 and File S2.
We present the act5C-gene as an easily detectable and quantifiable
positive control (via a C-terminal GFP-tag, see Figure 1) that may help
other researchers set up the technology in their own labs. With an
inverted microscope equipped with fluorescence illumination and a
GFP filter set, the first Act5C-GFP positive cells can already be seen
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about 3 d after the initial transfection. Their enrichment during the
selection procedure can also be observed. This model gene has allowed
us to optimize a series of parameters (see Figure 2) in our approach to
make the method highly efficient yet cost-effective.
Although cell culture is clearly a reduced system compared to in vivo
work, it can complement Drosophila experimental strategies with re-
spect to cell-autonomous phenomena. In fact, Drosophila S2-cells can
be cultured essentially without dedicated equipment; while sterile
working techniques are of course aided significantly by laminar flow
hoods, the cells can also be handled with proper care on a clean
laboratory bench. Since the popular Schneider’s medium contains
pH-buffering substances, cell culture incubators with CO2-control
are not required. If necessary, the cells can even be grown in a 25
incubator together with fly stocks (e.g., inside a plastic box). The
technique described in this manuscript is thus inexpensive to set up
(only requiring standard molecular biology equipment) and can be
employed in essentially any fly lab. Our stable cas9-expressing cell
line is a convenient simplification, but cotransfection of a cas9 ex-
pression plasmid is also possible (Bottcher et al. 2014). All plasmids
described in this manuscript have been deposited at Addgene (see
Table 1 for a full list of plasmid reagents).
MATERIALS AND METHODS
Molecular biology methods
All PCR primer sequences are listed in Table S1. The Act5C-GFP
targeting vector was constructed by inserting PCR-amplified homology
regions of 500 bp (upstream) and 420 bp (downstream) into the vector
pMH3 using the NotI/XhoI (upstream) and ClaI/HindIII (down-
stream) restriction sites. Note that, for the downstream homology
region, an internalHindIII site in the homologous sequence served
as a cloning site. The improved FLP-recombinase expression plas-
mid was constructed by amplifying the FLP sequence using pri-
mers Bam_NLS_FLPe_sense and Not_FLP_as, then digesting the
PCR product with BamHI/NotI followed by ligation into corre-
spondingly cleaved pMH5. Candidate clones were sequenced and
pKF295 was retained as it carries the desired P(2)-.S mutation
and the NLS. In addition, the corresponding FLP protein carries a
I(377)-.L substitution likely due to PCR mutagenesis, which we
estimate to be without major consequences. Plasmids for N-terminal
HR donor templates were generated through a combination of oligo-
nucleotide synthesis (details available on request), PCR, and restriction
enzyme cloning. All oligonucleotides for this manuscript were ordered
Figure 1 Optimization of tech-
nical aspects for the genomic
tagging approach. (A) The model
locus act5C can be efficiently
tagged with e.g., GFP. This al-
lows for easy quantification by
fluorescence microscopy or flow
cytometry. (B) PCR is used to
now directly fuse the optimized
sgRNA sequence with the U6 pro-
moter; this has allowed a simpler
PCR protocol and eliminates T7
in vitro transcription. For com-
pleteness, the HR donor PCR is
also depicted schematically on
the right. (C) Commercial PCR
buffers contain detergents that
interfere with transfection (aver-
age 6 SD, n = 3 biological rep-
licates). If PCR is performed in
detergent-free buffer, no purifica-
tion step is necessary. Both the
U6-sgRNA expression fragment
and the HR donor were amplified
in the respective buffer system.
The experiment was performed
with knockdown of lig4 only. (D)
The experimental workflow could
be simplified with direct U6 fusion
and detergent-free buffer. Essen-
tially, it suffices to perform two
PCR amplifications, then mix and
transfect the products. If the re-
cipient cells do not express cas9,
a cas9-encoding plasmid can be
transfected along with the PCR
products. GFP, green fluorescent
protein; HR, homologous recom-
bination; PCR, polymerase chain
reaction; SD, standard deviation;
sgRNA, single guide RNA.
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Figure 2 In vivo optimization of the tagging approach using the Act5C model locus and flow cytometry-based quantification of the Act5C-GFP tagging
success. (A) The optimal length of the target site complementary region of the sgRNA appears to be 18–19 nt (not counting the first G provided by the
U6-promoter, see detailed protocol); values depicted are the average 6 SD, n = 4 biological replicates, p-values: t-test. This is consistent with the
observations made by others (see text for references). (B) We extended our efforts to provide quantitative information about the tagging success rates to
five other loci. Shown are the GFP-positive cells detected one week after transfection, upon one round of Blasticidin-selection and after the second round
of Blasticidin-selection; depicted are the average values6 SD, n = 4 biological replicates. The expression levels of the tagged target loci can be estimated
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from Eurofins Genomics (Ebersberg, Germany). The copia-puromycin
resistance cassette was ordered as a synthetic gBlock fragment (IDT,
Coralville).
Cell culture
Culture ofDrosophila cells in Schneider’smedium (Bio& Sell, Nürnberg,
Germany) supplemented with 10% FBS and penicillin/streptomycin
(Life Technologies) and transfection conditions were as previously de-
scribed (Bottcher et al. 2014; Shah and Forstemann 2008). Details on the
transfection of PCR products are given in the detailed protocol provided
in File S1 and File S2. GFP expression was quantified using a Becton-
Dickinson FACScalibur flow cytometer; data analysis was performed
with Flowing Software 2.0 (http://www.flowingsoftware.com) using a
two-dimensional plot (SSC and GFP fluorescence) to separate nonfluo-
rescent from GFP-positive cells. Fluorescence microscopy images were
acquired on a Leica DM IRE2 confocal microscope. Induction of the
mtnDE promoter was achieved by adding CuSO4 from a sterile 100 mM
stock solution directly into the culture medium (final concentrations
between 30 mM and 1 mM). The effective concentrations are likely
somewhat lower since amino group-containing components from the
medium form complexes with copper ions (visible as a change to a slight
blue color with increasing concentrations). The conditions for induction
should therefore be verified if serum-free culture medium is employed.
Data availability
This article is accompanied by detailed experimental protocols provided
in File S1 and File S2. We maintain these protocols and the potentially
updated versions can be downloaded from our web-page: http://www.
foerstemann.genzentrum.lmu.de/protocols.
The described plasmids are available at Addgene (see Table 1 for
accession numbers) and we will provide the S2 cell line with stable cas9
expression upon request. This cell line is based on our laboratory stock
of S2 cells. The entire procedure described here can easily be transferred
to other cell lines or engineered cas9 protein variants by cotransfection
n Table 1 Currently available plasmids for the genomic tagging procedure











eGFP pMH3 52528 pSK23 72851 — —
twin-Strep pIW1 52530 pSK24 72852 — —
2 · Flag pMH4 52529 pSK25 72853 — —
TEV-V5(long) — — pSK32 72854 — —
TEV-V5(short) pKF296 74773 pKF297 74774 — —
PhiC31 attP site pSK15 72885 pSK41 74886 — —
Targeting vector Act5C-eGFP pIS1 74887 — — — —
N-terminal tag
Base vector pRB36 72861 pRB35 72866 pKF292 72856
3 · Flag pRB34 72862 pRB33 72867 pKF293 72857
1 · Strep pRB32 72863 pRB31 72868 pKF294 72858
Strep-His8-Strep-TEV pRB38 72864 pRB37 72869 pKF290 72859
eGFP pRB40 72865 pRB39 72870 pRB30 72860
sgRNA expression snRNA:U6:96Ac prom. pRB17 52527 — — — —
FLP-recombination NLS-FLP (P2-.S) pKF295 72871 — — — —
sgRNA, single guide RNA.
according to the mean intensity of the GFP-signal among the positive cell population (arb. units, see also Figure S1): Act5C-GFP = 293 6 42,
H2Av-GFP = 47 6 2, Nop56-GFP =19 6 2, Sec61-GFP = 18 6 2, ATPsyn-GFP = 16 6 1, Nup133-GFP = 5 6 0.3; the corresponding sgRNA
sequences are indicated above the respective bars. (C) If an optimally placed GG dinucleotide PAM (i.e., a CRISPR target site that will be
destroyed upon integration of the HR donor) cannot be found, the cas9 cleavage would also occur within the affected homology arm. A single
point mutation is sufficient to recover much of the tagging efficiency (left panel, average 6 SD, n = 3 biological replicates, p-values: t-test). If
cleavage occurs at the optimal position, one or two point mutations do not alter tagging efficiency (right panel, average 6 SD, n = 3 biological
replicates, p-values: t-test). Note that the values shown represent the initial targeting efficiency. Efficiencies were normalized to the average
number of GFP-positive cells obtained when cleavage occurred at the standard site and the homology region did not contain any point mutations
(right panel, “wt” bar). The error bars thus reflect both the biological variation for Act5C-GFP tagging and the technical variation of transfection
efficiency between replicates. This experiment was performed without depletion of lig4 andmus308 because repair via end-joining activities may
be required for mutagenesis after cleavage by cas9. (D) Left panel: To determine the optimal length of the homology region contained in the PCR
primers, we performed the Act5C-GFP tagging experiment with 40, 60, and 80 bp homology regions on either side. While 60 bp of homology
length did enhance the efficiency relative to 40 bp, further extension to 80 bp did not increase the efficiency (average 6 SD, n = 4 biological
replicates, p-values: t-test). We thus recommend using 60 bp of target homology on either side of the HR donor PCR product. Right panel: We
compared PCR-based HR donors with longer homology regions contained in a targeting vector (obtained by modification of the PCR template
vector). Note that for this panel, a concomitant lig4/mus308 knockdown was performed (average6 SD, n = 3 biological replicates, p-values: t-test;
see also Figure S2). (E) Concomitant knockdown of lig4 and mus308 improves the recovery of correctly genome-modified cells. The control
knockdown was dsRNA directed against Renilla reniformis luciferase. The efficiency in this experiment was 82 6 3% of Act5C-GFP-positive cells
for the lig4/mus308 knockdown (average 6 SD, n = 3 biological replicates, p-values: t-test). See also the left and right panels of Figure 2D. CRISPR,
Clustered regularly-interspaced short palindromic repeat; GFP, green fluorescent protein; HR, homologous recombination; PAM, protospacer
adjacent motif; PCR, polymerase chain reaction; RNAi, RNA interference; SD, standard deviation; sgRNA, single guide RNA; wt, wild-type.
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of a cas9 expression plasmid (e.g., pRB14). This strategy is slightly less
convenient but, with PCR product-based sgRNA delivery, reaches
nearly identical efficiencies (see Figure 5B in Bottcher et al. 2014).
The authors state that all data necessary for confirming the conclu-
sions presented in the article are represented fully within the article.
RESULTS AND DISCUSSION
Act5C-GFP as a positive control locus and model gene
for optimization
Since our original publication, we have strived for an improved and
simplified genome editing workflow. An important tool to assess
beneficial changes in the protocol is a model locus that allows for single
cell-based detection of the desired homology-directed modification
even before antibiotic selection. We have made extensive use of the
C-terminal addition of GFP to the act5C gene for this purpose. TheGFP
modification appears to be well tolerated in cells and can be scored by
fluorescence microscopy or flow cytometry as early as 3 d after the
transfection (Figure 1A).We also found this to be a very helpful positive
control to establish the workflow and to routinely confirm that cell
growth and transfection conditions were appropriate.
Improved sgRNA primer design and direct U6
promoter-sgRNA fusion
The use of DNA-based sgRNA expression constructs, rather than
in vitro transcribed RNA, has greatly simplified the experiment and
work in our laboratory now relies exclusively on this approach. In our
first publication (Bottcher et al. 2014), we had used the T7-promoter
present on the in vitro transcription template to generate a U6-promoter
fusion product by overlap extension PCR. Since we essentially aban-
doned in vitro transcription of the sgRNA, we designed a new primer
template that results in a direct fusion of the sgRNA sequence to the
U6:96Ac promoter contained on plasmid pRB17 (Bottcher et al. 2014).
Furthermore, we exchanged the sgRNA scaffold oligonucleotide for an
optimized version developed by the Weissman lab (Chen et al. 2013).
Generation of an sgRNA template by PCR is now a highly reliable,
single-step PCR (Figure 1B). Since the gene-specific sequence in the
oligonucleotide that bridges the U6-promoter with the sgRNA scaffold
does not participate in any annealing step during PCR,multiple different
sgRNA amplifications can be performed in parallel under identical
conditions. We recommend including a control amplification without
addition of the “programming” gene-specific oligonucleotide; this will
reveal if cross-contaminations have occurred.
Use of detergent-free PCR buffer eliminates the need
for purification
PCR products generated in commercial reaction buffers need to be
purified in order to reach acceptable transfection efficiencies. We hy-
pothesized that the detergent contained in the commercial buffers might
be the reason. Thus, we performed our PCR in self-made reaction buffer
that lacks detergent and transfected the products directly, i.e., without any
purification, enrichment, or precipitation step. As shown in Figure 1C,
the success rate was slightly higher than the one obtained with column-
purified material. Perhaps more importantly, this improvement was
reached with a greatly simplified experimental workflow (Figure 1D).
An optimal sgRNA length of 18–19 nucleotides
Wepreviously demonstrated that sgRNA length can be varied (Bottcher
et al. 2014), and others (e.g., Fu et al. 2014b) have demonstrated that
truncated sgRNAs provide improved efficacy and specificity for ge-
nome editing. Because there is only a narrow window for optimal
DNA cleavage sites in our genomic tagging strategy, few (if any) sgRNA
alternatives exist and strategies that improve cas9 cleavage specificity
and/or efficiency are thus beneficial. We optimized the length of
the target-matching region in the sgRNA and tested this using our
Act5C-GFP system. Consistent with previous observations (Fu et al.
2014b), we found that a length of 18–19 nucleotides (nt) appears to give
optimal efficiency. We did not test whether cleavage specificity was
concomitantly improved (as has been reported by others).
It is conceivable, if not obvious, that genome editing efficienciesmay
vary among targeted sites. We extended our flow cytometry-based,
quantitative analysis of C-terminal GFP-tagging efficiency from Act5C
(CG4027, X Chr.) to five additional loci: Nup-133 (CG6958, third
Chr.), Sec-61 a (CG9539, second Chr.), ATP synthase b (CG11154,
fourth Chr.), Nop56 (CG13849, third Chr.), and H2Av (CG5499, third
Chr.). These loci were chosen because of their specific localization
pattern, allowing for microscopic verification (see Figure S1), and be-
cause their expression levels allowed us to quantify the tagging success
via flow cytometry. We did not observe any anomalies in cell morphol-
ogy or grossly altered proliferation rates caused by the fusion proteins.
We could obtain efficiencies between 55–89% after two rounds of
Blasticidin selection (Figure 2B). This demonstrates that high targeting
success rates are not limited to the Act5C locus. However, the number
of loci we now present is still limited and their selection was not ran-
dom. We suggest considering the observed success rates of 55–89% as
the range that can be expected for modification of “permissive” loci. In
addition to potential chromatin structure-dependent hindrances for
DNA cleavage and repair, appending an epitope tag to cellular proteins
may interfere with their function. Our approach modifies the genomic
allele(s); dominant-negative or haploinsufficiency effects may thus also
reduce the yield of cells if the desired modification leads to protein
malfunction.
Are there any particular sequence features that determine the
efficiency of sgRNA cleavage? This is currently a matter of intense
debate and several publications have addressed this issue with diverging
conclusions (e.g., Housden et al. 2015; Moreno-Mateos et al. 2015; Ren
et al. 2014). We did not find any particular sequence feature that most
or all of the six sgRNAs we tested in Figure 2B have in common. This is
not too surprising, given the small number of loci, but it suggests that
sequence optimization of the sgRNAmay only have limited benefit. For
the purpose of introducing an epitope-tag at the N- or C-terminus of a
protein, the position where cas9-dependent cleavage must occur is
rather narrowly defined; cleavage further away from the start- or stop-
codon rapidly reduces overall efficiency (see Figure 2C). Therefore, if
sequence-based sgRNA selection rules are in clear conflict with the need
to cleave close to the desired integration site, we suggest choosing the
sgRNA sequence in favor of the best cleavage position. Obviously, re-
petitive sequences that are present in several instances throughout the
genome should nonetheless be avoided.
Single point mutations suffice to prevent cleavage at
target sites within homology regions
Sometimes the ideal situation, where the cas9 target site is disrupted
upon insertion of the HR donor, cannot be reached because an appro-
priately placed GG PAM is absent. In this case, the cas9 cleavage site
will be present, both in the genomic sequence close to the desired in-
tegration site and also in one of the flanking homology regions in the
HR donor. To prevent cleavage of the latter prior to integration, or
subsequent mutagenesis of the edited locus, a silent point mutation
should be introduced in the HR donor. We simulated this situation
by deliberately cleaving upstream of the act5C stop codon. Perhaps not
surprisingly, moving the cleavage site 20 bp away from the desired
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integration site reduced the efficiency of our genome editing procedure;
most likely, this is because the effective length of one homology arm is
correspondingly shortened. This efficiency reduction was particularly
obvious if HR donors with wild-type sequence were used, presumably
because the homology arm was cleaved off prior to integration or
because of secondary mutagenesis after integration. A single point
mutation within the corresponding HR donor primer was sufficient
to restore efficiency; increasing the number of mismatches to the
sgRNA sequence did not lead to further improvements (Figure 2C).
Homology arm lengths of 60 nt suffice for
optimal efficiency
Our approach relies on the incorporation of homology arms into PCR
primers during oligonucleotide synthesis. This is very convenient but
also represents themost expensive reagent in our protocol. Therefore, it
is imperative to minimize the length of these homology arms. We had
previously demonstrated that 26 bp can suffice for sequence-specific
integration, but the efficiencywas clearly lower thanwith80bp.Wehave
now compared homology arm lengths of 40, 60, and 80 bp (Figure 2D,
left panel). According to our results, homology arm lengths of 60 bp are
sufficient for optimal efficiency. While a shortening of the homology to
40 bp clearly reduced the efficiency, an extension to 80 bp did not result
in further improvement. To apply this analysis to even longer homol-
ogy arms, we generated an Act5C-GFP targeting vector (pIS1) by se-
quentially cloning homology arms of 500 bp upstream and 420 bp
downstream homology into our pMH3 template vector. We compared
this targeting vector in both circular and linearized form to PCR prod-
ucts with 60 and 80 bp of flanking homology (Figure 2D, right panel).
Increasing the homology arm length from 60/60 to 500/420 did not
result in an increased overall efficiency (Figure 2D, right panel) or
initial recombination rate (Figure S2). Note that in Figure 2D only
the right panel was generated with a concomitant lig4/mus308 knock-
down (see below), whereas the left panel was generated with only a lig4
knockdown.
Taken together, we recommend a homology arm length of 60 bp
oneachside formaximal efficiency; nonetheless, shorterhomologyarms
(e.g., 40 bp each) may be an acceptable compromise to reduce the costs
in large-scale efforts if a somewhat lower efficiency can be tolerated. It is
possible that extending the homology regions beyond 500 bp will result
in even higher targeting rates. Our interpretation is, however, that
beyond a size of 60 bp, the homology arm length is not the limiting
factor in this genome editing protocol.
Improved efficiency due to combined knockdown of
lig4 and mus308
The selection of genome-modified cells by resistance to the antibiotic
blasticidin-S has allowed us to significantly enrich the desired outcome
in the final cell population. However, cells may also become resistant if
the HR donor construct integrates spontaneously at a random position
within the genome.We refer to these events as “off-site” integrations, to
distinguish them from the “off-target” cleavage that may occur with the
cas9 nuclease. As originally demonstrated with mutant flies (Carroll
et al. 2008), transient depletion of DNA ligase 4 by RNAi reduces these
off-site integrations and increases the yield of desired cells (Bottcher
et al. 2014). This beneficial effect can be further enhanced by a con-
comitant depletion of the DNA polymerase u ortholog mus308, an
enzyme that is important duringmicrohomology-mediated end joining
(Figure 2E). In experiments where a concomitant knockdown of lig4
andmus308was combinedwith a 19 nt optimal-length sgRNA and 60 nt
long homology arms, we could reproducibly achieve an Act5C-GFP
targeting rate of . 65% among the selected population (Figure 2, B and
E and unpublished results). This is likely sufficient for many applica-
tions that rely on a gain-of-function approach, such as the introduction
of epitope tags or fluorescent markers. Note that some of the experi-
ments in this manuscript (Figure 1C and Figure 2, A and D, left pane)
were performed using only a lig4 knockdown. The parameters that we
optimized in these tests are unlikely to be affected by the additional
mus308 knockdown. In principle, a combination of lig4 and mus308
alleles should be beneficial for homology-directed genome editing in
injected fly embryos or other organisms as well; however, we observed
that the two genes display synthetic lethality at higher dsRNA doses.
Extension of the approach to N-terminal tags
We extended our approach to the introduction of N-terminal protein
tags. To this end, a new template vector design had to be developed that
also comprises a promoter for heterologous expression of the tagged
gene. This is necessary because, in the case of an N-terminal tag, the
selection cassette separates the endogenous promoter from the gene
body. We chose the inducible, bidirectional mtnDE promoter for this
purpose. Induction is possible by adding e.g., CuSO4 to the growth
medium and the promoter can drive expression of the selectionmarker
and the tagged protein concomitantly. In addition, we combined the
mtnDE-driven expression of the tagged gene with constitutively active
marker cassettes, to select modified cells without the need for induction
of the tagged gene. This may be helpful if expression of the resulting
fusion gene is toxic (e.g., due to overexpression, generation of N-terminal
truncations, misexpression etc.). As for the C-terminal approach, our
vector templates bear constant regions for annealing of the homology-
containing targeting primers during PCR. All N-terminal tags
and selection constructs can thus be amplified with a single set of
HR-containing primers (summarized in Figure 3). We have devel-
oped N-terminal vector templates for GFP, the 3 · Flag epitope, a
single Strep-tag, and a combined Strep-His8-Strep-TEV tag; the
latter one can be removed from the purified protein by TEV-cleavage
(see Table 1 for an overview of all template vectors currently available at
Addgene). The His8-sequence allows removal of the cleaved tag from
the reaction along with the usually His-tagged TEV protease protein.
The tag may also be used for tandem affinity purification (we recom-
mend to start with Ni-NTA beads and use Streptactin beads as the
second step). Since the selection cassette is flanked by FRT-sites in all
vectors, it can be removed with FLP recombinase to restore expression
control by the endogenous promoter. Note that both the N- and
C-terminal template vectors can easily be modified, e.g., using re-
striction enzyme-based cloning to harbor other tags, fluorescent
proteins, or elements for genome functionalization. For example,
we generated template vectors that allow the introduction of an attP
target site based on the C-terminal epitope tag template series (see
Table 1).
Heterologous control of gene expression by the
mtnDE promoter
Ifall alleles foragivengene in theS2-cell genomehavebeenmodified(see
File S1 and File S2 for clonal selection of cells and PCR genotyping
strategies), the introduced mtnDE-promoter allows heterologous con-
trol over the expression of the targeted gene. As an example, we derived
cell lines with N-terminally GFP-tagged Dcr-2 protein. After clonal
selection, we could readily identify cells that carried only modified
dcr-2 alleles. These lines allowed us to tune the expression level of
Dcr-2; analysis by FACS and western blotting demonstrated that both
transcriptional shut-off and overexpression situations can be obtained
(Figure 4). We have not extensively characterized the leakiness of the
mtnDE promoter in the noninduced state, but preliminary results
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indicate that the transcript levels are comparable to those observed after
RNAi (data not shown; this likely also varies according to the genomic
position). For simple loss-of-function approaches, RNAi is far easier to
apply; however, the mtnDE promoter “alleles” may present an inter-
esting tool to study genetic interaction in combination with RNAi of a
second factor. In particular, they may be convenient to create hypo-
morphic expression levels of essential genes in order to make them
amenable for synthetic genetic screens.
Generation of an improved FLP-recombinase
expression vector
We reasoned that if a robustly expressed gene is N-terminally GFP-
tagged with our system, then the efficiency of marker-cassette FLP-out
can be quantified by measuring the proportion of GFP-positive cells in
the absence of CuSO4, once expression is again driven by the endoge-
nous promoter. We designed oligonucleotides targeting the twinstar
(tsr) gene, a highly expressedDrosophila homolog of cofilin. Stable and
clonal cell populations were selected and flow cytometry was used to
verify that all cells in the populations became GFP-positive after CuSO4
induction (data not shown). Successful cassette FLP-out could then be
measured as the amount of GFP-positive cells following transfection of a
FLP-recombinase expression plasmid. The measured GFP-fluorescence
intensities were lower than what we had expected based on published tsr
expression levels; nonetheless, the system allows reliable quantification
of the successful FLP-out events. We had previously described an ex-
pression vector for wild-type Saccharomyces cerevisiae FLP recombinase
(pMH5) and noticed that the efficiency of FLP-out was somewhat lim-
ited. Improved versions of the FLP recombinase have been described
(Buchholz et al. 1998) and we appended an N-terminal nuclear locali-
zation signal in combination with the proline(2) -. serine substitution
to generate plasmid pKF295. Using the GFP-tsr test system in three
separate clonal cell lines, we found that transfection of pKF295 approx-
imately doubled the amount of GFP-positive cells compared to pMH5
(Figure 4B). In absolute terms, a FLP-out efficiency of 5–10% (pMH5)
and 10–20% (pKF295) could be reached. Considering the transfection
efficiency of 60%, the higher values correspond to about one third
(pKF295) and one fifth (pMH5) of the transfected cells.
Introduction of a second selection cassette
To enable straightforward introduction of a second epitope tag (e.g., for
coimmunoprecipitation studies), we developed an independent selec-
tion cassette based on the puromycin acetyl transferase gene. Since the
Figure 3 Template vectors for N-terminal tagging. Top row: schematic representation of the three different vector template series used for
N-terminal tagging. In the first series (left), the inducible and bidirectional mtnDE promoter drives the expression of the Blasticidin-resistance
gene. We recommend adding CuSO4 to a concentration of 100 mM or higher 2 d prior to transfer into selective medium. Constitutive expression
(driven by the copia promoter) of the Blasticidin or Puromycin resistance genes occurs, respectively, when the second (center) or third (right) series
of templates is employed. Note that a single HR-containing primer set can be used with any of these templates. Bottom: Sequence details of the
different N-terminal tags for which we developed template vectors. AmpR, ampicillin resistance; BlastR, blasticidin resistance; FRT, Flp recombi-
nase target; GFP, green fluorescent protein; His, histidine; HR, homologous recombination; TEV, tobacco etch virus protease cleavage site.
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Figure 4 Heterologous control of gene expression with the mtnDE promoter and quantification of FLP-out efficiency. (A) We could generate clonal
cell populations where all dcr-2 alleles had been modified to include an N-terminal GFP tag. Prior to marker excision, this allows for heterologous and
tunable control of GFP-Dcr-2 expression levels. We quantified the amount of modified Dcr-2 protein per cell by comparing the N-terminal fusions
(bottom left) with a C-terminal fusion (top left) that presumably reflects the endogenous level of Dcr-2 expression. We estimate that, in this particular
case, a CuSO4 concentration of 30–50 mM leads to wild-type expression levels. Western blotting experiments with a monoclonal antibody directed
against the endogenous protein confirmed the absence of untagged protein and that CuSO4 concentrations between 30–50 mM led to wild-type
equivalent expression. The mtnDE promoter allows the tuning of expression levels within a roughly tenfold range (see western blot on top right and
flow cytometry quantification on bottom right), but absolute levels may vary between genes. (B) An N-terminal GFP-tag at the twinstar (tsr) locus
served as a test-platform to determine the FLP-out efficiency. The left panel depicts the experimental approach: In the absence of CuSO4, no
GFP-expression is detectable in cells that harbor one or more edited tsr alleles. Upon FLP-mediated recombination between the FRT sites flanking
the marker gene andmtnDE-promoter, transcription of the fusion gene is again controlled by the endogenous tsr promoter and GFP-tsr fluorescence
can be measured and quantified by flow cytometry. This is depicted in the right panel for three clonal cell populations carrying modified tsr alleles.
Untransfected cells and cells transfected with a luciferase-expression plasmid served as controls; we compared our previously published FLP
expression vector (pMH5) with an improved version (pKF295). The depicted values are the mean 6 SD, n = 4 biological replicates (clone 21: 5
biological replicates), p-values: t-test. FRT, Flp recombinase target; GFP, green fluorescent protein; SD, standard deviation.
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commonly used coding sequence of this gene proved to be rather re-
fractory to PCR amplification (likely due to a high GC content), we
created a copia-Puro resistance cassette as a synthetic gene. This element
could be readily amplified by PCR and we have generated alternative
versions of most template vectors by exchanging the copia-Blast cassette
with the copia-Puro marker (see Figure 3 and Table 1). As a general
proof-of-principle, we show the introduction of a C-terminal twin-Strep
tag (pSK24-based, see Table 1) at the Dcr-2 locus (Figure S3). We
observed that our S2-cell line is quite sensitive to puromycin; selection
works well at a concentration of 0.5 mg/ml of puromycin in Schneider’s
medium. Integration of a puromycin construct in a blasticidin-resistant
cell line (or vice versa) is efficient and does not require any changes to
the protocol (data not shown). We have not quantified the tagging
efficiencies with puromycin resistance-based constructs in a manner
analogous to the experiments shown, e.g., in Figure 2. The tagging
success rates clearly depend on optimal sgRNA length and the extent
of homology arms in the HR donor PCR product; since these elements
are independent of the marker chosen, we do not expect major quan-
titative differences between puromycin and blasticidin-based selections.
In principle, the two constructs could also be integrated in parallel
rather than sequentially. Indeed, we have been able to recover cells that
underwent corresponding multiplex genome editing. However, these
cells are very rare in the initial population due to the rather low initial
targeting frequency (3–10%). As a consequence, themultiplexed editing
approach is not very robust and more time is required until sufficient
cells have grown for downstream analysis. We therefore recommend
sequential introduction if multiple epitope tags need to be combined
within the same cell. If one begins with an inducible blasticidin
resistance construct for an N-terminal tag (pKF290-294 or pRB30,
see Table 1) and then continues with constitutive puromycin and
blasticidin resistance cassettes, up to three epitope tags can be com-
bined without the need to FLP out the marker in between.
Conclusions
In this publication, we describe a simplified genome editing protocol
with increased efficiency, an extension to N-terminal epitope tags and
the application of a second, independent selection cassette for our
PCR-based genome editing of cultured Drosophila cells. Table 1
summarizes all of the template vectors that we have developed to
date. The genomic tagging system now offers significantly increased
functionality, including the possibility to verify protein–protein in-
teractions via coimmunoprecipitation. The improved primer design
to generate U6-sgRNA expression cassettes has made the system
much more robust and enables the reliable generation of reagents
for many genes in parallel. Due to the use of PCR rather than
cloning, our experimental approach is flexible, scalable, and can
easily accommodate future changes (e.g., different sgRNA designs,
novel epitope tags). We estimate that it should be straightforward to
extend our strategy to other Drosophila cell culture systems, poten-
tially even to cultured cells from other insect species. Related PCR-
based approaches have been described for use in cultured vertebrate
cells (Li et al. 2014; Stewart-Ornstein and Lahav 2016). We expect
that our vector templates can be modified for use beyond insect cells
by exchanging the copia-promoter used for selection and/or the
inducible mtnDE promoter with sequences of corresponding func-
tionality in, e.g., vertebrate cells. Perhaps more importantly, it may
be possible to transfer the conclusions from our optimization efforts
to other cell culture systems as well.
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